This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Ontario Health Study | |
|---|---|
| Name | Ontario Health Study |
| Abbreviation | OHS |
| Established | 2000s |
| Location | Ontario, Canada |
| Type | prospective cohort study |
| Participants | hundreds of thousands |
Ontario Health Study The Ontario Health Study is a large-scale prospective cohort study based in Ontario that investigates risk factors for chronic diseases including cancer, diabetes mellitus, and cardiovascular disease. Funded and partnered by institutions such as Institute for Clinical Evaluative Sciences, University of Toronto, and provincial research networks, the study links questionnaire data, physical measures, and administrative databases to follow participants across multiple decades. The initiative supports research on environmental exposures, genetics, health services, and population health interventions with collaboration from academic centers, biobanks, and public health agencies.
The study operates as a cohort platform similar in scope to the UK Biobank, Nurses' Health Study, and Million Veteran Program to enable nested case-control and cohort analyses of outcomes like breast cancer, colorectal cancer, and ischemic heart disease. It integrates biospecimen collection and electronic health record linkage with regional datasets such as the Canadian Institute for Health Information holdings and provincial health administrative databases. Designed to support multidisciplinary teams from institutions including McMaster University, Queen's University, Western University, and research institutes such as the Hospital for Sick Children.
Origins trace to provincial health priorities articulated by bodies like the Ministry of Health and Long-Term Care (Ontario) and strategic initiatives promoted by the Canadian Institutes of Health Research. Early pilot phases involved collaborations with population cohorts such as Canadian Longitudinal Study on Aging and international consortia including the European Prospective Investigation into Cancer and Nutrition. Expansion phases incorporated partnerships with biobanking initiatives like the Ontario Institute for Cancer Research and technology platforms from companies and institutions similar to Illumina and academic core facilities at McGill University (through cross-provincial projects).
The cohort uses a prospective observational design permitting time-to-event analyses, nested case-control studies, and genome-wide association study workflows akin to protocols from the Framingham Heart Study and Rotterdam Study. Methodological frameworks include standardized questionnaires, repeat measures, and linkage to administrative outcomes such as hospitalization records from CIHI and mortality registries maintained by provincial vital statistics. Genotyping and sequencing follow pipelines comparable to those used in the 1000 Genomes Project and analytical methods such as Mendelian randomization employed in studies like those from the Wellcome Trust.
Recruitment strategies employed media campaigns, institutional outreach, and clinical partnerships with networks like Cancer Care Ontario and primary care organizations such as Ontario College of Family Physicians affiliates. The cohort includes adults across urban centers such as Toronto, Ottawa, Hamilton, Ontario, and rural regions in Northern Ontario, reflecting demographic variation in age, sex, ancestry, and socioeconomic status. Substudies oversampled populations associated with regional programs like Indigenous health initiatives linked to organizations such as the Nishnawbe Aski Nation and community health centers associated with Métis Nation of Ontario outreach.
Data elements encompass self-reported health history, lifestyle factors, medication inventories, and validated instruments employed in cohorts like the International Physical Activity Questionnaire and dietary modules aligned with the Canadian Community Health Survey. Physical measures include anthropometry, blood pressure, spirometry, and biospecimens (blood, saliva) processed in facilities similar to the Ontario Genomics Institute core labs. Linkages permit capture of outcomes from pathology services, cancer registries such as the Ontario Cancer Registry, and prescription data analogous to provincial drug benefits programs.
Governance structures involve academic steering committees, data access committees, and community advisory boards patterned after frameworks used by Tri-Council Policy Statement guidance and institutional review boards at Sunnybrook Health Sciences Centre and St. Michael's Hospital. Ethics oversight emphasizes informed consent, privacy protections parallel to the Personal Health Information Protection Act, 2004, and data-sharing agreements that enable secure access for investigators from entities including Public Health Ontario, international collaborators from the Harvard T.H. Chan School of Public Health, and industry partners under controlled conditions. Researchers apply via data access protocols similar to those at the Canadian Longitudinal Study on Aging.
Research leveraging the cohort has produced evidence on risk factor associations for type 2 diabetes mellitus, cardiovascular outcomes such as myocardial infarction, and cancer incidence patterns including prostate cancer and lung cancer. Publications have examined environmental exposures, gene–environment interactions using methods from the International HapMap Project, and health services research comparing utilization patterns akin to analyses by CIHI. Major outputs appear in journals with editorial communities at outlets such as The Lancet, Nature Genetics, BMJ, and JAMA and inform provincial policy dialogues involving stakeholders like the Ontario Health agency and academic health science networks.
Category:Cohort studies